EyePoint Pharmaceuticals, Inc. Annual Interest Expense in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
EyePoint Pharmaceuticals, Inc. quarterly/annual Interest Expense history and growth rate from 2016 to 2023.
  • EyePoint Pharmaceuticals, Inc. Interest Expense for the quarter ending June 30, 2024 was $0.000, a 100% decline year-over-year.
  • EyePoint Pharmaceuticals, Inc. Interest Expense for the twelve months ending June 30, 2024 was $0.000, a 100% decline year-over-year.
  • EyePoint Pharmaceuticals, Inc. annual Interest Expense for 2023 was $1.25M, a 60.9% decline from 2022.
  • EyePoint Pharmaceuticals, Inc. annual Interest Expense for 2022 was $3.19M, a 42% decline from 2021.
  • EyePoint Pharmaceuticals, Inc. annual Interest Expense for 2021 was $5.5M, a 24.2% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.25M -$1.94M -60.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-08
2022 $3.19M -$2.31M -42% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-08
2021 $5.5M -$1.76M -24.2% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-10
2020 $7.26M +$1.08M +17.5% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-14
2019 $6.18M +$3.81M +161% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-12
2018 $2.36M +$2.36M Jan 1, 2018 Dec 31, 2018 10-K 2020-03-16
2017 $0 $0 Jul 1, 2016 Jun 30, 2017 10-KT 2019-03-18
2016 $0 Jul 1, 2015 Jun 30, 2016 10-KT 2019-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.